Polymyxin B Protocol — Complete Dosing & Administration Guide

Dosing

How muchdo I take?

Intramuscular: An injection into a muscle, usually the thigh, shoulder, or buttock.

Bioavailability High — well absorbed into the bloodstream from the muscle.

Standard Dose

25,000-30,000 units/kg/day divided every 4-6 hours

Frequency

Every 4-6 hours

Duration

Infection-dependent

FDA label intramuscular dosing; not generally recommended due to injection-site pain. [6]

Timing

Best time to take

Polymyxin B is administered intravenously in a clinical setting. Timing is determined by your healthcare provider based on the treatment protocol and your medical needs.

With food?

IV administration of Polymyxin B is not dependent on meal timing. Your healthcare team will provide specific instructions regarding food and fluid intake around treatment sessions.

If stacking

Polymyxin B should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

+You've tolerated the current dose for the recommended period without significant side effects

+Therapeutic goals haven't been met at the current dose level

+Your healthcare provider recommends dose escalation based on your response

+Lab work or clinical assessments support a higher dose

Decrease if

-Side effects are bothersome or impacting daily life despite management strategies

-You experience any signs of an adverse reaction

-Lab results indicate the need for dose reduction

-Your healthcare provider recommends a lower dose based on your response

Signs of right dose

✓Therapeutic goals being met with minimal side effects

✓Stable and consistent response to treatment

✓Lab values or clinical markers trending in the right direction

✓Good tolerance with manageable or absent side effects

Dosing Calculator

Calculate Your Exact Dose

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The peptide weight is printed on the label

The weight is on the label

Select Weight

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do Iuse it?

Reconstitution

What you need

•Polymyxin B vial (lyophilized powder or solution)

•Bacteriostatic water or sterile sodium chloride for reconstitution

•Alcohol swabs for cleaning vial tops and injection sites

•Appropriately sized syringes with fine-gauge needles (27-30 gauge)

•Sharps disposal container

Example

Add the recommended volume of bacteriostatic water to the Polymyxin B vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.

Your dose of Polymyxin B is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.

Injection

Route

Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training

Best sites

•Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection

•Front of thighs—middle to upper portion of the outer leg

•Back of upper arm—outer area (may need assistance from another person)

Technique

1.Wash your hands thoroughly with soap and water before handling supplies

2.Clean the injection site with an alcohol swab and let it air dry completely

3.Pinch a fold of skin at the chosen injection site

4.Insert the needle at a 45-90 degree angle (depending on needle length and body composition)

5.Inject the medication slowly and steadily over 5-10 seconds

6.Release the skin fold and remove the needle, applying gentle pressure with a clean swab

7.Rotate injection sites to prevent tissue irritation or lipodystrophy

8.Dispose of the needle safely in a sharps container—never recap or reuse needles

Storage

Before reconstitution

Store Polymyxin B in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Polymyxin B should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

Solution appears cloudy, discolored, or contains visible particles (should be clear)

Product has been exposed to temperatures outside the recommended storage range

Product has been frozen (unless specifically designed for freeze-thaw stability)

Expiration date has passed or reconstituted solution has exceeded its use-by date

Unusual odor, color change, or visible contamination

Sample Daily Schedule

As prescribed (twice daily)

As prescribed by your healthcare provider injection

Site: Intravenous infusion (primary systemic route)—rotate sites if applicable

Maintain a consistent schedule for optimal results with Polymyxin B. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is itsafe?

Safety Profile

Polymyxin B carries significant nephrotoxicity risk (acute tubular necrosis) and neurotoxicity risk (peripheral neuropathy, neurological effects) requiring strict monitoring. Serum concentrations >5 mg/L associated with increased renal dysfunction; dosing adjusted for creatinine clearance to minimize accumulation. IV or intramuscular use only; intrathecal administration reserved for meningitis with careful dosing. Bacterial resistance monitoring essential as polymyxins remain reserved antibiotics.

Clinical pharmacokinetic studies document polymyxin B mechanism through lipopolysaccharide binding (LPS) neutralization assays. Renal safety monitoring via creatinine clearance and cystatin C shows dose-dependent decline in GFR. Neurotoxicity correlates with serum levels >5 mg/L; electromyography studies show reversible neuromuscular junction effects. Meningitis studies show CSF penetration adequate for bacterial killing despite narrow therapeutic window.

Common Side Effects

Experienced by some users

Nephrotoxicity

Acute kidney injury reported in 34-60% of patients receiving IV polymyxin B. Manifests as rising serum creatinine, decreased urine output, and renal tubular injury. Typically appears within the first week of treatment. Risk increases with higher doses, longer duration, and concurrent nephrotoxic agents.

Management: Monitor renal function (creatinine, BUN, urine output) every 24-48 hours. Ensure adequate hydration. Avoid concurrent nephrotoxins when possible. Dose-adjust or switch agents if creatinine rises >2x baseline. Nephrotoxicity is usually reversible upon discontinuation.

Infusion-related histamine release

Flushing, pruritus, urticaria, chest tightness, and hypotension during IV infusion. Caused by direct polymyxin B-induced mast cell degranulation and histamine release. Dose-rate dependent.

Management: Infuse slowly over 1-2 hours (never IV push). Pre-medicate with diphenhydramine or H1-blocker if prior reaction. Reduce infusion rate if symptoms occur. Usually manageable without discontinuation.

Neurotoxicity

Perioral paresthesias (numbness/tingling around mouth), peripheral paresthesias in extremities, dizziness, and vertigo in 5-15% of patients. Dose-dependent and usually reversible.

Management: Monitor for neurological symptoms daily. Usually mild and self-limiting. Dose reduction may be needed if symptoms are significant. Resolves after treatment completion.

Skin hyperpigmentation

Progressive skin darkening, particularly in sun-exposed areas and head/neck region, with prolonged IV polymyxin B courses. Related to histamine-mediated stimulation of melanogenesis. Reported in 8-15% of patients.

Management: Cosmetic concern — not medically dangerous. Usually reversible over weeks to months after discontinuation. Sun protection may help minimize progression.

Less Common

•Neuromuscular blockade

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

×Severe or worsening side effects that don't improve with dose adjustment or supportive care

×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing

×Your healthcare provider recommends discontinuation based on your clinical response

×Development of any new medical condition that may be contraindicated with Polymyxin B

×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)

×Abnormal lab results or clinical markers that suggest adverse effects

Polymyxin B should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Interactions

With other peptides

✓May be used together under medical guidance.

With medications

!Aminoglycosides (gentamicin, tobramycin, amikacin) — additive nephrotoxicity and neurotoxicity; use combination only when absolutely necessary with intensive renal monitoring - Use with caution—discuss with your healthcare provider.

!Vancomycin at full doses — additive nephrotoxicity; if combination needed, monitor renal function daily - Use with caution—discuss with your healthcare provider.

!Neuromuscular blocking agents (succinylcholine, vecuronium) — polymyxin B potentiates neuromuscular blockade, risk of prolonged paralysis and respiratory failure - Use with caution—discuss with your healthcare provider.

With supplements

✓Multivitamins - Generally safe to take alongside Polymyxin B. Space doses apart if taking oral formulations to ensure optimal absorption.

✓Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Want the Full Picture?

View the complete Polymyxin B research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.